Table 3.
Effects of B. dracunculifolia extract (5–200 mg kg−1) and sulfasalazine (25 mg kg−1) on GSH content, MPO activity and AP activity in TNBS acute colitis
| Group | GSH content (nmol g−1 tissue) | MPO activity (U g−1 tissue) | AP activity (mU mg−1 protein) |
|---|---|---|---|
| Non-colitic | 1357.5 ± 86.5** | 84.2 ± 8.7** | 6.24 ± 0.36* |
| TNBS control | 759.6 ± 31.9 | 684.2 ± 62.8 | 12.62 ± 1.72 |
| B. dracunculifolia | |||
| 5 mg kg−1 | 967.3 ± 55.0* | 324.9 ± 89.9** | 10.53 ± 1.21 |
| 10 mg kg−1 | 850.3 ± 27.8 | 532.8 ± 96.3 | 14.58 ± 1.36 |
| 25 mg kg−1 | 878.5 ± 82.7 | 576.4 ± 79.8 | 14.27 ± 2.02 |
| 50 mg kg−1 | 809.4 ± 55.0 | 216.9 ± 31.6** | 6.16 ± 0.63* |
| 100 mg/kg−1 | 873.8 ± 25.8 | 245.8 ± 39.9** | 7.45 ± 0.93 |
| 200 mg kg−1 | 930.9 ± 113.8 | 380.1 ± 84.4* | 9.54 ± 1.76 |
| Sulfasalazine | 1006.2 ± 87.0* | 419.8 ± 80.1* | 9.02 ± 1.56 |
Data are expressed as mean ± SEM. *P < .05, **P < .01 versus TNBS control group.